Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hominal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revue De Pneumologie Clinique|April 3, 2001
[Pleural mesothelioma]I Monnet, S Hominal
Revue De Pneumologie Clinique|April 3, 2001
[Treatment of small-cell bronchial cancer]S Hominal, I Monnet
Presse Medicale (Paris, France : 1983)|June 15, 1999
[Carcinomatous lymphangitis]S Hominal, L Falchero, M Perol, et al.
Revue Des Maladies Respiratoires|May 14, 2013
[Epidemiology, management and cost of bone metastases from lung cancer]C Decroisette, L-M Galerneau, S Hominal, et al.
Revue De Pneumologie Clinique|February 28, 2001
[Post-cardiac aggression syndrome: a case report]C Louerat, S Hominal, M Perol, et al.
Revue De Pneumologie Clinique|April 27, 2016
[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG]M Grivaux, B Duvert, P Ferrer-Lopez, et al.
Respiratory Medicine and Research|July 9, 2021
Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG studyT Payen, J Trédaniel, L Moreau, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2020
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France projectH Blons, J-B Oudart, J-P Merlio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revue De Pneumologie Clinique|April 3, 2001
[Pleural mesothelioma]I Monnet, S Hominal
Revue De Pneumologie Clinique|April 3, 2001
[Treatment of small-cell bronchial cancer]S Hominal, I Monnet
Presse Medicale (Paris, France : 1983)|June 15, 1999
[Carcinomatous lymphangitis]S Hominal, L Falchero, M Perol, et al.
Revue Des Maladies Respiratoires|May 14, 2013
[Epidemiology, management and cost of bone metastases from lung cancer]C Decroisette, L-M Galerneau, S Hominal, et al.
Revue De Pneumologie Clinique|February 28, 2001
[Post-cardiac aggression syndrome: a case report]C Louerat, S Hominal, M Perol, et al.
Revue De Pneumologie Clinique|April 27, 2016
[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG]M Grivaux, B Duvert, P Ferrer-Lopez, et al.
Respiratory Medicine and Research|July 9, 2021
Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG studyT Payen, J Trédaniel, L Moreau, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2020
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France projectH Blons, J-B Oudart, J-P Merlio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 1